Home » Topics » Regulatory

Regulatory
RSS

New MS treatment approved in Israel

Nov. 15, 1996

New formulation of Leukine approved by FDA

Nov. 15, 1996

New formulation of amifostine covered by U.S. patent

Nov. 15, 1996

First chemotherapeutic drug approved for advanced hormone-refractory prostate cancer

Nov. 15, 1996

Collaborative combination drug trial to begin in HIV-infected patients

Nov. 15, 1996

ASA + ibuprofen combination effective in treating Listeria infection in mice

Nov. 15, 1996

NDA submitted for breakthrough pain Rx

Nov. 15, 1996

American Biogenetic Sciences' blood clot diagnostic test cleared for marketing

Nov. 8, 1996

FDA advisory committee deems ACEL-IMUNE safe and effective for use in infants

Nov. 8, 1996

More convenient formulation of Lodine approved

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026